| Literature DB >> 16254802 |
Ulrik B Nielsen1, Brigit Schoeberl.
Abstract
Computational biology is impacting drug design and has the potential to revolutionize the drug development process. Here, we describe how data-driven computational models can optimize the design of targeted therapeutics to yield improved safety and efficacy. We propose that, in the future, this approach will improve drug discovery, clinical development, diagnosis and treatment.Mesh:
Year: 2005 PMID: 16254802
Source DB: PubMed Journal: IDrugs ISSN: 1369-7056